Marc Benioff an Insider in, inc. (CRM) Sold 10,000 Shares; Amag Pharmaceuticals (AMAG) Sellers Increased By 0.13% Their Shorts

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Logo

Amag Pharmaceuticals Inc (NASDAQ:AMAG) had an increase of 0.13% in short interest. AMAG’s SI was 8.34 million shares in April as released by FINRA. Its up 0.13% from 8.33 million shares previously. With 815,800 avg volume, 10 days are for Amag Pharmaceuticals Inc (NASDAQ:AMAG)’s short sellers to cover AMAG’s short positions. The SI to Amag Pharmaceuticals Inc’s float is 28.77%. The stock increased 4.90% or $0.95 during the last trading session, reaching $20.35. About 801,632 shares traded. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has declined 16.25% since April 4, 2017 and is downtrending. It has underperformed by 27.80% the S&P500.

AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Ratings Coverage

Among 14 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. AMAG Pharmaceuticals had 46 analyst reports since August 18, 2015 according to SRatingsIntel. Morgan Stanley maintained it with “Overweight” rating and $22 target in Friday, November 3 report. Jefferies maintained AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) rating on Wednesday, August 16. Jefferies has “Buy” rating and $34.0 target. As per Friday, February 3, the company rating was downgraded by Cowen & Co. Cantor Fitzgerald maintained AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) on Thursday, November 2 with “Hold” rating. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) earned “Hold” rating by Cantor Fitzgerald on Thursday, February 1. The company was reinitiated on Thursday, September 3 by Deutsche Bank. Cantor Fitzgerald maintained AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) rating on Monday, June 26. Cantor Fitzgerald has “Hold” rating and $2300 target. The company was maintained on Wednesday, February 14 by Cantor Fitzgerald. The stock has “Hold” rating by Cantor Fitzgerald on Monday, July 24. Janney Capital upgraded AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) on Thursday, February 15 to “Buy” rating.

Since February 23, 2018, it had 0 buys, and 1 insider sale for $16,016 activity. 770 AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) shares with value of $16,016 were sold by Vittiglio Joseph.

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, makes, develops, and commercializes therapeutics for womenÂ’s health, anemia management, and cancer supportive care in the United States. The company has market cap of $693.71 million. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme , an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. It currently has negative earnings. The firm also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units for pregnant women and their families.

Investors sentiment decreased to 0.9 in Q4 2017. Its down 0.54, from 1.44 in 2017Q3. It turned negative, as 29 investors sold AMAG Pharmaceuticals, Inc. shares while 53 reduced holdings. 24 funds opened positions while 50 raised stakes. 37.72 million shares or 5.64% less from 39.98 million shares in 2017Q3 were reported. Wells Fargo Mn holds 61,684 shares or 0% of its portfolio. Dupont Management Corporation holds 0.01% or 30,031 shares in its portfolio. Mason Street Ltd Llc holds 0% or 9,200 shares. Texas Permanent School Fund accumulated 23,912 shares. Panagora Asset Management Inc has 306,041 shares for 0.02% of their portfolio. Price T Rowe Associates Incorporated Md stated it has 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). D E Shaw And Inc has 0.02% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Highland Capital Mgmt Lp holds 61,500 shares. The Maryland-based Adams Diversified Equity Fund has invested 0.02% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). The Colorado-based Pub Employees Retirement Association Of Colorado has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Jabre Prns owns 0.22% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 80,216 shares. Goldman Sachs Group owns 231,655 shares. 116,800 were accumulated by Spark Investment Mgmt Ltd Liability Co. Qs Invsts Lc reported 0.01% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Whittier Tru, California-based fund reported 2,292 shares.

The stock increased 1.03% or $1.19 during the last trading session, reaching $116.49. About 5.19 million shares traded., inc. (NYSE:CRM) has risen 39.46% since April 4, 2017 and is uptrending. It has outperformed by 27.91% the S&P500.

Investors sentiment decreased to 1.19 in 2017 Q4. Its down 0.15, from 1.34 in 2017Q3. It fall, as 39 investors sold, inc. shares while 274 reduced holdings. 110 funds opened positions while 261 raised stakes. 608.21 million shares or 0.25% less from 609.74 million shares in 2017Q3 were reported. Mycio Wealth Prns holds 0.03% of its portfolio in, inc. (NYSE:CRM) for 3,115 shares. The Nebraska-based Farmers & Merchants Invs Inc has invested 0.01% in, inc. (NYSE:CRM). 183,731 are held by Victory Mgmt Incorporated. South Africa-based Old Mutual Customised Solutions (Proprietary) Ltd has invested 0.34% in, inc. (NYSE:CRM). Jpmorgan Chase Company owns 4.74 million shares. Winslow Evans And Crocker Incorporated owns 5,658 shares. Macquarie Gru Limited invested in 0.03% or 182,630 shares. Tudor Invest Corp Et Al holds 2,333 shares. Morgens Waterfall Vintiadis reported 3.3% in, inc. (NYSE:CRM). Paradigm Asset Mngmt Communication Ltd Com holds 0.05% of its portfolio in, inc. (NYSE:CRM) for 1,850 shares. Hutchin Hill L P stated it has 0.38% in, inc. (NYSE:CRM). Pillar Pacific Cap Ltd Liability Com has 0.93% invested in, inc. (NYSE:CRM) for 74,294 shares. Manchester Management Ltd Llc stated it has 0% in, inc. (NYSE:CRM). Moreover, Bnp Paribas Arbitrage Sa has 0.34% invested in, inc. (NYSE:CRM). Bamco Incorporated holds 0.02% or 41,509 shares in its portfolio.

Since October 3, 2017, it had 3 buys, and 133 selling transactions for $89.25 million activity. Benioff Marc sold 5,000 shares worth $534,182. The insider Harris Parker sold 1,750 shares worth $205,275. Roos John Victor also sold $14,616 worth of, inc. (NYSE:CRM) on Thursday, February 1. Conway Craig had sold 542 shares worth $69,414. Dayon Alexandre had sold 8,477 shares worth $855,499 on Friday, October 27. $26,187 worth of, inc. (NYSE:CRM) was sold by Martinez Maria on Sunday, February 25. The insider BLOCK KEITH sold 10,000 shares worth $1.19M.

Among 54 analysts covering (NYSE:CRM), 48 have Buy rating, 1 Sell and 5 Hold. Therefore 89% are positive. has $150.0 highest and $18 lowest target. $115.45’s average target is -0.89% below currents $116.49 stock price. had 230 analyst reports since August 21, 2015 according to SRatingsIntel. The stock has “Hold” rating by Jefferies on Thursday, February 25. The firm has “Buy” rating by Oppenheimer given on Wednesday, August 19. Credit Suisse maintained the stock with “Outperform” rating in Wednesday, August 23 report. Wunderlich maintained, inc. (NYSE:CRM) on Thursday, September 1 with “Buy” rating. BTIG Research initiated the shares of CRM in report on Thursday, September 10 with “Buy” rating. The stock of, inc. (NYSE:CRM) earned “Buy” rating by Mizuho on Monday, November 13. As per Friday, June 24, the company rating was initiated by Cowen & Co. BMO Capital Markets maintained, inc. (NYSE:CRM) rating on Thursday, March 1. BMO Capital Markets has “Outperform” rating and $133 target. The firm has “Outperform” rating by Cowen & Co given on Thursday, March 1. The firm has “Outperform” rating given on Thursday, May 19 by Credit Suisse.

Stock trade totalling close to $1,154,012 U.S Dollars was revealed in a form submitted to the SEC on April 3, 2018. According to which, Marc Benioff, the Chairman of the Board and CEO of Salesforce Com Inc also an insider of the stock exchange listed company had sold a total of 10,000 shares – ( at $115.4 a share ). He also sold 85,000 shares worth total $10,382,049 USD in the last month. The probability of this trade staying a secret is extremely low due to its volume, with the Chairman of the Board and CEO right now owning 33.25 million shares —- that is 4.54% of the total market capitalization of the company., inc. develops enterprise cloud computing solutions with a focus on customer relationship management. The company has market cap of $85.32 billion. The firm offers Sales Cloud to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices, as well as solutions for partner relationship management. It has a 685.24 P/E ratio. It also provides Service Cloud, which enables companies to deliver personalized customer service and support, as well as connects their service agents with clients on various devices; and Marketing Cloud to plan, personalize, and optimize one-to-one customer interactions., inc. (NYSE:CRM) Institutional Positions Chart